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Aim: To examine the cross-sectional and longitudinal associations of patellar bone marrow lesion (BMLs)
with knee pain, cartilage defects and cartilage volume in older adults.
Methods: A total of 904 randomly selected subjects (mean 62.4 years, 49.9% female) were studied. Fat
suppressed T1-weighted spoiled gradient recall and T2-weighted fast spin echo magnetic resonance
imaging (MRI) sequences were used to assess cartilage volume, cartilage defects and/or BMLs at baseline
(n ¼ 904) and 2.6 (range: 1.4e4.8) years' follow-up (n ¼ 414). Knee pain was assessed by self-
administered Western Ontario McMaster Osteoarthritis Index (WOMAC) questionnaire at baseline
(n ¼ 904) and follow-up (n ¼ 790).
Results: The prevalence of any patellar BMLs was 19% and was higher in those with tibiofemoral BMLs. In
multivariable analyses, patellar BMLs were positively associated with any knee pain at baseline and an
increase in knee pain when going up/down stairs (odds ratio (OR): 1.67, 95% conﬁdence interval (CI):
1.08, 2.59) but not with other knee pain subscales. Patella BMLs were also associated with patellar
cartilage defects both at baseline and change over time (OR: 1.76, 95% CI: 1.00, 3.70) but not tibiofemoral
defects. Patellar BMLs were negatively associated with baseline and change in patella cartilage volume
(b: 2.10%, 95% CI: 3.39%, 0.80%). These associations remained signiﬁcant after further adjustment for
tibiofemoral BMLs.
Conclusions: Patellar BMLs were consistently associated with increased knee pain especially going up/
down stairs, increased patellar cartilage defects, and decreased patellar cartilage volume cross-
sectionally and longitudinally, suggesting a predominantly compartment speciﬁc role for patellar BMLs.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) of the knee is characterised by structural
abnormalities of whole joint including subchondral bone and
cartilage. Magnetic resonance imaging (MRI) has revolutionalisedo: C. Ding, Private Bag 23,
; Fax: 61-3-62267704.
ng).
to this work.
ternational. Published by Elsevier Lthe assessment of joint structural changes in OA. Recently, bone
marrow lesions (BMLs) have been recognized as an important
feature of knee OA as they are associated with both clinical and
structural outcomes1,2. Both human and animal studies have shown
that subchondral bone changes such as BMLsmay precede cartilage
damage3,4. Epidemiological studies have consistently reported that
baseline BMLs are associated with cartilage defects and cartilage
volume loss5e7. There is increasing but not totally consistent evi-
dence that BMLs are associated with knee pain1,8e13. Most of these
studies have focused on BMLs at tibial and femoral sites6,7,14,15, andtd. All rights reserved.
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femur5,16e18.
Patella plays an important role in knee joint mechanics and any
abnormality in patella may lead to change in function of the knee
joint. Patellofemoral OA is very common and is an important
contributor to anterior knee pain and disability19. It can co-exist
with tibiofemoral OA but most studies have focussed on tibiofe-
moral rather than patellofemoral OA20. Similarly, most studies on
BMLs have focused on tibiofemoral joint and it remains unclear
whether patellar BMLs have a similar role as tibiofemoral BMLs in
predicting knee pain and local cartilage changes.
A recent study reported that patellofemoral BMLs were associ-
ated with incident knee symptoms and patellofemoral cartilage
damage21; and another study reported that the risk factors for
short-term progressive cartilage loss differed between tibiofemoral
and patellofemoral compartments, and BMLs strongly predicted
cartilage loss only in tibiofemoral compartment, suggesting
potentially different roles of BMLs in these two compartments
regarding structural progression22. We hypothesized that patellar
BMLs were associated with knee pain and joint pathological
changes compartment-speciﬁcally. Aim of this population-based
cohort study was, therefore, to describe the cross-sectional and
longitudinal association between baseline patellar BMLs and knee
pain, cartilage defects and cartilage volume in older adults.
Materials and methods
Subjects
The subjects were participants of the Tasmanian Older Adult
Cohort (TASOAC) study, an ongoing prospective, population-based
study that was initiated in 2002 and aimed to identify environ-
mental, genetic, and biochemical factors associated with the
development and progression of OA. Subjects (n ¼ 1100) between
ages of 50 and 80 years were randomly selected from the electoral
roll in Southern Tasmania (population 229,000), with an equal
number of men and women. The response rate to the invitations at
baseline was 57%. Institutionalized persons and subjects with
contraindications to MRI were excluded (n ¼ 196). All research
conducted within this manuscript is in compliance with the Hel-
sinki Declaration and was approved by the Southern Tasmanian
Health andMedical Human Research Ethics Committee. All subjects
gave informed written consent. Self-report of rheumatoid arthritis
was recorded by questionnaire.
Anthropometrics
Weight was measured to the nearest 0.1 kg (with shoes, socks,
and bulky clothing removed) using a single pair of electronic scales
(Seca DeltaModel 707, Bradford, MA, USA). Height wasmeasured to
the nearest 0.1 cm (with shoes and socks removed) using a stadi-
ometer. Body mass index (BMI) was calculated (kg/m2).
Knee pain assessment
Knee pain was assessed using self-administered Western
Ontario McMaster Osteoarthritis Index (WOMAC) scale with a 10-
point scale from 0 (no pain) to 9 (most severe)23 at baseline and
follow-up. Each component of knee pain (walking on ﬂat surface,
going up/down stairs, at night, sitting/lying, and standing upright)
was summed to create total pain (0 to 45), and the presence of knee
painwas deﬁned as a total score or a subscale score of1. Change in
knee pain was calculated by subtracting baseline total or a subscale
score from follow-up total or a subscale score. An increase in knee
pain was deﬁned as a change in the score of 1.MRI
MRI scans of the right knees were performed at baseline and
follow-up. Knees were imaged in the sagittal plane on a 1.5-T whole
body magnetic resonance unit (Picker, Cleveland, OH) with use of a
commercial transmit-receive extremity coil. Image sequence
included the following: (1) a T1-weighted fat saturation three-
dimensional (3-D) gradient recall acquisition in the steady state,
ﬂip angle 30, repetition time 31 ms, echo time 6.71 ms, ﬁeld of
view 16 cm, 60 partitions, 512  512-pixel matrix, acquisition time
5 min 58 s, one acquisition; sagittal images were obtained at a
partition thickness of 1.5 mmwithout between-slice gap; (2) a T2-
weighted fat saturation 2-D fast spin echo, ﬂip angle 90, repetition
time 3067 ms, echo time 112 ms, ﬁeld of view 16 cm, 15 partitions,
228  256-pixel matrix; sagittal images were obtained at a parti-
tion thickness of 4 mm with a between-slices gap of 0.5e1.0 mm.
Subchondral BML evaluation
Subchondral BMLs were assessed by a trained observer on T2-
weighted MR images and was deﬁned as areas of increased signal
adjacent to the subcortical bone (Fig. 1). Patellar and femoral
trochlear BMLs were scored using a modiﬁed version of Whole-
Organ Magnetic Resonance Imaging Score (WORMS) of the knee24.
Largest lesion among the multiple MR image was selected and
scored. A scale from 0 to 3 was used, where 0 ¼ absence, 1 ¼ <25%,
2 ¼ 25% to 50%, and 3 ¼ >50% of the patellar or trochlear area. The
intraobserver reliability of patellar BMLs in this study, expressed as
intraobserver correlation coefﬁcient (ICC), was 0.94. Presence of
patellar or trochlear BMLs was deﬁned as a score of BMLs of 1.
Other knee subchondral BMLs were assessed by a trained observer
using the same grading system at baseline and follow-up on a T2-
weighted MRI at the medial tibial, medial femoral, lateral tibial,
and lateral femoral sites, and the intraobserver reliability was
0.89e1.00, as previously described25.
Cartilage morphology evaluation
Knee cartilage volume was determined on T1-weighted MR
images with image processing on an independent workstation
using Osiris software (University of Geneva, Geneva, Switzerland),
as previously described26,27. Total cartilage volumewas divided into
patellar, medial and lateral tibial cartilage volume by manually
drawing disarticulation contours around the cartilage boundaries,
section by section, which were then resampled for the ﬁnal 3-
dimensional rendering26. The coefﬁcients of variation (CVs) for
this method in our hands were 2.1% to 2.6%26.
Cartilage defects (0e4 scale) were determined at medial tibial,
medial femoral, lateral tibial, lateral femoral, and patellar sites as
previously described (Fig. 2)19,20. We graded the cartilage according
to the severity of the damage: grade 0 ¼ normal cartilage; grade
1 ¼ focal blistering and intracartilaginous low-signal intensity area
with an intact surface; grade 2 ¼ irregularities on the surface or
bottom and loss of thickness <50%; grade 3 ¼ deep ulceration with
loss of thickness >50%; grade 4¼ full-thickness chondral wear with
exposure of subchondral bone. The presence of a cartilage defect
was deﬁned as a cartilage defect score of 2 at one site. Intra-
observer reliability was 0.89e0.94 and interobserver reliability was
0.85e0.9319. BMLs, cartilage volume measurements and cartilage
defects were all done independent of each other.
Statistical analysis
T-tests or c2 tests were used to compare differences in means or
proportions as appropriate. Univariable and multivariable binary
Fig. 1. Patellar BMLs were assessed by a modiﬁed version of WORMS. a. grade
1 ¼ <25% (arrowheads); b. grade 2 ¼ 25% to 50% (arrowheads); c. grade 3 ¼ >50%
(arrowheads).
Fig. 2. Patellar cartilage defect progression from a) grade 2 at ba
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between patellar BMLs and both baseline and increases in tibiofe-
moral BMLs, cartilage defects and WOMAC knee pains, before or
after adjustment for age, sex, BMI and rheumatoid arthritis. Uni-
variable and multivariable linear regression analyses were used to
examine the associations between patellar BMLs and baseline or
changes in knee cartilage volume, both before and after adjustment
for the covariates. These associations were further adjusted for
tibiofemoral BMLs. A P-value <0.05 (2-tailed) or a 95% conﬁdence
interval (CI) not including the null point (for linear regression) or 1
(for logistic regression) was considered statistical signiﬁcance. All
statistical analyses were performed on SPSS version 20.0 for Win-
dows (SPSS Inc., Chicago, IL).Results
Characteristics of the subjects
A total of 904 subjects (49.8% female) aged between 50 and 80
(mean: 62.4 years) participated in this study and were included in
the analysis. There were no signiﬁcant differences in demographic
factors (age, sex, and BMI) between these participants and those
excluded due to contra indication to MRI (n ¼ 196) (data not
shown). The prevalence of any patellar BMLs was 19%, with 151
subjects (87 females, 64 males) having grade 1, 15 (7 females, 8
males) having grade 2 and 4 subjects (all females) having grade 3.
Baseline characteristics of the participants are presented in
Table I. The prevalence of any knee pain at baseline was 51.4%. 9% of
the subjects increased their pain status from baseline and 76%
remained unchanged. The prevalence of patellar cartilage defects at
baseline was 40% and follow up was 47%. 11% of subjects had a
progression of their patellar cartilage defects and 88% of subjects
remained in the same grade. There were no signiﬁcant differences
between subjects with and without patellar BMLs in terms of age,
BMI, tibial cartilage volume and tibial bone size. However, subjects
with patellar BMLs had signiﬁcantly lower patellar cartilage volume
and higher percentage of female sex, tibiofemoral BMLs, tibiofe-
moral cartilage defects, patellar cartilage defects and total knee
pain.
Over 2.6 years, 114 subjects were lost to the follow-up study due
to: 28 deceased, 20 moved to other states or overseas, 15 had joint
replacement, 28 physically unable, and others refused or no reason.
The remaining 790 subjects completed the follow-up study and the
ﬁrst 414 had the follow-up MRI scans. The rest of the subjects did
not complete the follow-up MRI scans due to the decommissioningseline (arrowhead) to b) grade 4 at follow-up (arrowhead).
Table I
Baseline characteristics of the participants
Total sample Without patellar BMLs With patellar BMLs P-value
n ¼ 904 n ¼ 734 n ¼ 170
Age (year) 62.4 (7.4) 62.3 (7.4) 62.7 (7.4) 0.551
Female sex (%) 49.9 48 58 0.025
BMI (kg/m2) 27.7 (4.6) 27.7 (4.6) 27.7 (4.6) 0.964
Any knee pain (%) 51.4 49 69 <0.001
Medial tibial cartilage volume (ml) 2.3 (0.6) 2.3 (0.6) 2.3 (0.6) 0.416
Lateral tibial cartilage volume (ml) 2.8 (0.7) 2.8 (0.7) 2.7 (0.7) 0.733
Patella cartilage volume (ml) 3.2 (0.9) 3.3 (0.9) 2.9 (0.9) <0.001
Medial tibial bone area (cm2) 20.9 (3.1) 21.0 (3.1) 20.6 (3.0) 0.186
Lateral tibial bone area (cm2) 12.2 (2.2) 12.2 (2.2) 12.2 (2.0) 0.925
Presence of other knee BMLs (%) 34.6 31 51 <0.001
MTF cartilage defects (%) 24.1 22 33 0.001
LTF cartilage defects (%) 22.3 20 32 0.001
Patellar cartilage defects (%) 40.4 30 83 <0.001
Two-tailed t tests used for differences between means; c2 test used for proportions (percentages).
Signiﬁcant differences are shown in bold.
Mean (SD) except for percentages. BMI: body mass index; BMLs: bone marrow lesions; MTF: medial tibiofemoral; LTF: lateral tibiofemoral.
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ferences in baseline characteristics between subjects who had
follow-up MRI and those who did not have follow-up MRI as pre-
viously reported28. Patellar BMLs were signiﬁcantly associated with
an increase in any tibiofemoral BMLs and change in tibiofemoral
BMLs total score (all P < 0.05) in multivariable analyses.Patellar BMLs and knee pain
There were signiﬁcant associations between baseline patellar
BMLs and baseline total WOMAC knee pain or pain when going up/
down stairs, but not with other pain subscales, before and after
adjustment for age, sex, BMI and rheumatoid arthritis in cross-
sectional analyses. Longitudinally, baseline patellar BMLs were
associated with an increase in knee pain when going up/down
stairs over 2.6 years, but not with increases in total pain and other
pain subscales (Table II). The associations with baseline pain and an
increase in pain when going up/down stairs remained signiﬁcant
after further adjustment for tibiofemoral BMLs (Table II). WeTable II
Associations between patellar BMLs and WOMAC knee pain and an increase in
WOMAC knee pain over 2.6 years
Univariable OR
(95% CI)
Multivariable*
OR (95% CI)
Multivariabley
OR (95% CI)
Knee pain at baseline (Yes/No)
Total WOMAC knee pain 1.68 (1.19, 2.36) 1.68 (1.18, 2.38) 1.52 (1.06, 2.16)
Pain on ﬂat surface 1.17 (0.81, 1.69) 1.18 (0.81, 1.73) 1.05 (0.71, 1.55)
Pain on stairs 1.67 (1.19, 2.33) 1.67 (1.18, 2.35) 1.52 (1.07, 2.16)
Pain in bed 1.16 (0.81, 1.67) 1.14 (0.79, 1.65) 1.07 (1.04, 1.56)
Pain when sitting 0.92 (0.62, 1.35) 0.90 (0.61, 1.34) 0.85 (0.57, 1.27)
Pain when standing 0.86 (0.59, 1.27) 0.85 (0.57, 1.26) 0.74 (0.49, 1.12)
Increase in knee painz
Total WOMAC knee pain 1.26 (0.79, 2.00) 1.32 (0.82, 2.12) 1.22 (0.76, 1.99)
Pain on ﬂat surface 1.24 (0.72, 2.13) 1.33 (0.77, 2.32) 1.13 (0.64, 2.00)
Pain on stairs 1.59 (1.04, 2.44) 1.67 (1.08, 2.59) 1.57 (1.01, 2.46)
Pain in bed 1.08 (0.62, 1.87) 1.13 (0.65, 1.96) 1.12 (0.64, 1.96)
Pain when sitting 1.31 (0.75, 2.29) 1.35 (0.77, 2.39) 1.29 (0.72, 2.29)
Pain when standing 1.16 (0.67, 2.02) 1.19 (0.68, 2.09) 1.11 (0.63, 1.97)
Knee pain is deﬁned as a pain score of 0 (vs. no pain).
Increase in knee pain is deﬁned as a change in the score of 1 from baseline to
follow-up (vs. no increase).
* Adjusted for age, sex, BMI and rheumatoid arthritis.
y Further adjusted for tibiofemoral BMLs.
z Further adjusted for interval between two visits. Signiﬁcant differences are
shown in bold.assessed patellar BMLs at follow-up, and found that change in
patellar BMLs was not signiﬁcantly associated with changes in total
knee pain or change in knee pain when going up or down stairs
(data not shown).
Patellar BMLs and cartilage defects
Cross-sectionally, baseline patellar BMLs were signiﬁcantly and
strongly associated with patellar cartilage defects, and, to a lessser
extent, with femoral cartilage defects, but not with tibial cartilage
defects in univariable and multivariable analyses (Table III). The
association between patellar BMLs and patellar cartilage defects
remained unchanged, but those between patellar BMLs and femoral
cartilage defects became non-signiﬁcant after further adjustment
for tibiofemoral BMLs (Table III). Longitudinally, baseline patellar
BMLs were signiﬁcantly associated with an increase in patellar
cartilage defects, but not with tibial and femoral BMLs, both before
and after adjustment (Table III). The association between patellar
BMLs and an increase in patellar cartilage defects remained largely
unchanged after further adjustment for tibiofemoral BMLsTable III
Associations between patellar BMLs and cartilage defects and increases in cartilage
defects over 2.6 years
Univariable
OR (95% CI)
Multivariable*
OR (95% CI)
Multivariabley
OR (95% CI)
Cartilage defects at baseline (Yes/No)
Medial tibial 1.11 (0.64, 1.91) 1.18 (0.67, 2.09) 0.87 (0.47, 1.60)
Medial femoral 1.69 (1.16, 2.47) 1.67 (1.13, 2.48) 1.39 (0.92, 2.10)
Lateral tibial 1.37 (0.90, 2.08) 1.38 (0.90, 2.13) 1.08 (0.68, 1.71)
Lateral femoral 1.83 (1.12, 2.97) 2.01 (1.22, 3.32) 1.64 (0.97, 2.76)
Patellar 11.07 (7.21, 17.01) 12.99 (8.28, 20.39) 11.94 (7.58, 18.79)
Increases in cartilage defects over 2.6 years‡
Medial tibial 1.74 (0.92, 3.27) 1.87 (0.98, 3.59) 1.68 (0.87, 3.25)
Medial femoral 0.86 (0.48, 1.53) 0.88 (0.49, 1.58) 0.83 (0.46, 1.51)
Lateral tibial 1.40 (0.75, 2.61) 1.43 (0.76, 2.68) 1.30 (0.69, 2.46)
Lateral femoral 1.49 (0.84, 2.65) 1.74 (0.96, 3.14) 1.57 (0.86, 2.88)
Patellar 1.73 (1.01, 2.97) 1.75 (1.01, 3.05) 1.76 (1.00, 3.10)
Presence of a cartilage defect was deﬁned as a cartilage defect score of 2 (yes vs
no).
An increase in cartilage defect is deﬁned as a change in cartilage defects of 1 from
baseline to follow-up (vs. no increase).
* Adjusted for age, sex, BMI and rheumatoid arthritis.
y Further adjusted for tibiofemoral BMLs.
z Further adjusted for interval between two visits. Signiﬁcant differences are
shown in bold.
Table IV
Associations between patellar BMLs and cartilage volume and changes in cartilage volume over 2.6 years
Univariable b (95% CI) Multivariable* b (95% CI) Multivariabley b (95% CI)
Cartilage volume at baseline (mm3)
Medial tibial 41.5 (141.6, 58.6) 25.2 (55.6, 106.0) 46.2 (35.0, 127.5)
Lateral tibial 20.7 (140.2, 98.7) 67.7 (24.9, 160.3) 78.5 (15.1, 172.1)
Patellar ¡454.4 (¡609.6, ¡299.3) ¡345.7 (¡471.0, ¡220.4) ¡296.4 (¡421.4, ¡171.3)
Change in cartilage volume % per annum
Medial tibial 1.2 (2.58, 0.14) ¡1.4 (¡2.7, ¡0.02) 1.1 (2.5, 0.2)
Lateral tibial ¡1.3 (¡2.45, ¡0.16) ¡1.2 (¡2.4, ¡0.07) 1.0 (2.2, 0.1)
Patellar ¡2.2 (¡3.51, ¡0.90) ¡2.1 (¡3.4, ¡0.80) ¡2.1 (¡3.5, ¡0.8)
Signiﬁcant differences are shown in bold.
* Adjusted for age, sex, BMI and rheumatoid arthritis.
y Further adjusted for tibiofemoral BMLs.
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associated with change in patellar cartilage defects (OR: 2.13 per
grade, 95% CI: 1.31, 3.46).
Patellar BMLs and cartilage volume
Cross-sectionally, baseline patellar BMLs were signiﬁcantly and
negatively associated with baseline patellar cartilage volume but
not with medial and lateral tibial cartilage volume in univariable
and multivariable analyses (Table IV). Longitudinally, patellar BMLs
were signiﬁcantly and negatively associated with change in patellar
cartilage volume before and after adjustment (Table IV). The sig-
niﬁcant associations remained after further adjustment for tibio-
femoral BMLs (Table IV). In addition, baseline patellar BMLs were
negatively associated with change in medial and lateral tibial
cartilage volume but the associations became non-signiﬁcant after
further adjustment for tibial BMLs (Table IV). Change in patellar
BMLs over 2.6 year was not signiﬁcantly associated with change in
cartilage volume over 2.6 years (data not shown).
The results remained largely unchanged when participants with
rheumatoid arthritis were excluded from analyses, or after
adjustment for a combined score of cartilage defects and BMLs at
tibiofemoral compartments, or baseline patellar cartilage defects
(data not shown). Trochlear BMLs were signiﬁcantly associated
with total WOMAC pain, knee pain when going up or down stairs,
patellar cartilage defects and patellar cartilage volume cross-
sectionally, but were not associated with increases in pain or
cartilage pathology longitudinally (data not shown).
Discussion
To the best of our knowledge, this study is the ﬁrst to describe
the independent associations between patellar BMLs and knee
clinical and cartilage abnormalities in older people. We found that
patellar BMLs were associatedwith knee painwhen going up/down
stairs, patellar cartilage defects and patellar cartilage volume loss
both cross-sectionally and longitudinally. Patellar BMLs were also
signiﬁcantly associated with tibial cartilage loss but these associa-
tions were not independent of tibial BMLs. Femoral trochlear BMLs
were associated with the outcome measures cross sectionally, but
not longitudinally, suggesting that trochlear BMLs may not as
important as patellar BMLs in inducing joint pain and structural
changes.
Presence of BMLs in tibiofemoral compartments is one of the
typically morphological abnormalities of subchondral bone related
to OA in MRI studies1. However, the exact type of pathology
involved with these lesions is not known. Previous research found
that tibiofemoral BMLs pattern zone mainly consisted of normal
tissue (53% of the area was fatty marrow, 16% was intact trabeculae,and 2% was blood vessels) and a smaller proportion of several ab-
normalities (bone marrow necrosis [11% of area], necrotic or
remodelled trabeculae [8%], bone marrow ﬁbrosis [4%], bone
marrow oedema [4%], and bone marrow bleeding [2%])29. Possible
cross-talk between subchondral bone and cartilage could induce
catabolism of the cartilage30,31 and can lead to pathological changes
in cartilage. Histology of patellar BMLs has not been reported but
should be similar with tibiofemoral BMLs, as we found that patellar
BMLs were associated with increased tibiofemoral BMLs. The un-
derlying reasons for the association between baseline patellar BMLs
and increases in tibiofemoral BMLs are unclear but it may reﬂect
the shared risk factors or similar mechanisms.
Knee pain is the most common symptom of knee OA and nearly
half of the adult population over age of 50 has pain8. Sources of
knee pain in OA are becoming clearer. We previously reported that
tibiofemoral BMLs were associated with knee pain32. Consistent
with this, patellar BMLs were associated with pain when going up/
down stairs independent of tibiofemoral BMLs. Sharma et al. have
reported similar results where isolated patellofemoral BMLs were
associated with prevalent, incident and persistent knee symp-
toms21. Patella faces more pressure when going up/down stairs
than other movements and the pressure triggered by BMLs could
stimulate the nociceptive ﬁbers around the patella and cause pain.
Anterior knee pain resulting from the patellofemoral OA has been
known to be refractory to treatment19, and patellar BMLs could be a
main reason for anterior knee pain in patellofemoral OA. Currently
there are no effective treatments for BMLs except for zoledronic
acid that was shown to reduce BMLs and knee pain33. Therefore,
targeting BMLs such as using zoledronic acid may be an effective
treatment for anterior knee pain in patellofemoral OA.
Studies have suggested that subchondral bonemay play a role in
cartilage degradation34, and adjoining trabecular changes may be
necessary for the progression of OA35. We previously reported that
the tibiofemoral BMLs are associated with compartment speciﬁc
cartilage defects and cartilage loss5. However, it remains unclear
whether patellar BMLs have similar effects. We found that the
presence of patellar BMLs in older adults was associated with
patellar cartilage changes over 2.6 years, independent of tibiofe-
moral BMLs. These changes included patellar cartilage volume loss
and patellar cartilage defect development/progression. Although
patellar BMLs were associated with tibial cartilage volume loss, the
associations decreased in magnitude and became non-signiﬁcant
after adjustment for tibial BMLs. These suggest that there is only
local effect of patellar BMLs on cartilage. Roemer et al. reported that
patellofemoral BMLs were associated with patellofemoral cartilage
loss over 6 months, but was dependent on prevalent cartilage de-
fects22. We found that these associations remained signiﬁcant after
further adjustment with baseline patellar cartilage defects or
tibiofemoral cartilage defects and BMLs indicating the independent
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the evidence for site-speciﬁc association between BMLs and carti-
lage changes with novel results at the patellar site.
Our results provide further support for the concept that sub-
chondral bone changes may be primary and can lead to cartilage
change27. The health and integrity of knee cartilage may be
dependent on the mechanical properties of the underlying sub-
chondral bone. Disrupted bone may be incapable of dissipating the
forces on the joint during motion which can lead to cartilage
breakdown, and it may also inhibit nutritional ﬂow from bone
marrow space to cartilage14. Subchondral bone has rich blood
supply and is therefore responsive to the treatment. There are
clinical trials utilising tibiofemoral BMLs as the outcome measure
for the treatment of knee OA33. Patellar BMLs are potentially a new
target for slowing cartilage loss in the therapy of patellofemoral OA.
There are a number of potential limitations to our study. We
used a modiﬁed version of WORMS to score patellar BMLs and the
numbers of subjects with grade 2 (15 subjects) and grade 3 (4
subjects) were low. This scoring was based on the largest dimen-
sion of BML in one slide, which may not represent the volume of
BML. We were unable to separate BMLs into different types, e.g.,
traumatic bone contusions and fractures, osteonecrosis and bone
infarcts, inﬂammation, tumour, transient idiopathic bone marrow
oedema, red marrow and post-surgical alterations36, because we
didn't have speciﬁc imaging, patient characteristics, symptoms, and
history to distinguish them. Patellar and tibiofemoral BMLs were
assessed by different readers which may underestimate their cor-
relations; however, tibiofemoral BMLs were only used for adjust-
ment in the models to examine the independent associations of
patellar BMLs. Another limitation of the study was that cartilage
assessment was performed using a fat-suppressed T1-weighted
gradient-echo sequence acquired in a single plane on a 1.5T im-
aging system which is not longer considered state-of the-art for
evaluating articular cartilage. Thus, the ability to detect small su-
perﬁcial cartilage lesions such as ﬁbrillation and ﬁssuring and to
identify subtle changes in the size and depth of cartilage lesions
over time was limited. Cartilage defect scoring system was mostly
dependent on the depth of the defect and not the cross sectional
area, which may not capture the full progression of cartilage de-
fects. However, it has been validated as accurate and reproducible37.
The response rate for this study at baseline was 57%, possibly due to
extensive protocol required for subjects in this old age group. This
might have introduced a selection bias to our study. However, there
were no signiﬁcant differences in age, gender and BMI between
those who responded and those who did not respond to our study
invitation. We also had high rates of retention (82%) to offset this.
We did not have a lateral or skyline radiographs to assess patello-
femoral radiographic OA, so cannot comment on the association of
patellar BMLs with patellofemoral radiographic OA. Lastly, mea-
surement error may inﬂuence results. However, all measures were
highly reproducible suggesting this is unlikely.
Conclusions
Patellar BMLs were consistently associated with increased knee
pain especially going up/down stairs, increased patellar cartilage
defects, and decreased patellar cartilage volume both cross-
sectionally and longitudinally, suggesting a predominantly
compartment speciﬁc role for patellar BMLs.
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